Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression

Human Pathology

Volumn 44, Issue 3, 2013, Pages 374-387

  Brozyna, Anna A ^a   Jóźwicki, Wojciech ^a   Janjetovic, Zorica ^b   Slominski, Andrzej T ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Melanogenesis; Melanoma; Tumor progression; Vitamin D

Indexed keywords

KI 67 ANTIGEN; OXYGENASE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANINS; MELANOMA; MIDDLE AGED; NEVUS, PIGMENTED; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; VITAMIN D; YOUNG ADULT;

EID: 84873733072     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.03.031     Document Type: Article

References (38)

1. T.T. Wang, L.E. Tavera-Mendoza, and D. Laperriere Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes Mol Endocrinol 19 2005 2685 2695
2. D.D. Bikle The vitamin D receptor: a tumor suppressor in skin Discov Med 11 2011 7 17
3. H. Chen, B. Hu, E.A. Allegretto, and J.S. Adams The vitamin D response element-binding protein: a novel dominant-negative regulator of vitamin D-directed transactivation J Biol Chem 275 2000 35557 35564
4. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture Endocrinology 108 1981 1083 1086
5. J.C. Fleet Molecular actions of vitamin D contributing to cancer prevention Mol Aspects Med 29 2008 388 396
6. 3-1α-hydroxylase in the human kidney J Am Soc Nephrol 10 1999 2465 2473
7. 3 production by human keratinocytes: kinetics and regulation J Clin Invest 78 1986 557 566
8. J. Radermacher, B. Diesel, and M. Seifert Expression analysis of CYP27B1 in tumor biopsies and cell cultures Anticancer Res 26 2006 2683 2686
9. N. Lopes, B. Sousa, and D. Martins Alterations in vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions BMC Cancer 10 2010 483
10. J.N. Flanagan, L.W. Whitlatch, and T.C. Chen Enhancing 1 alpha-hydroxylase activity with the 25-hydroxyvitamin D-1 alpha-hydroxylase gene in cultured human keratinocytes and mouse skin J Invest Dermatol 116 2001 910 914
11. M.F. Holick Vitamin D: A millenium perspective J Cell Biochem 88 2003 296 307
12. J. Reichrath, L. Rafi, and M. Rech Analysis of the vitamin D system in cutaneous squamous cell carcinomas J Cutan Pathol 31 2004 224 231
13. 3-1- hydroxylase in normal and malignant human colon Cancer Epidemiol Biomarkers Prev 14 2005 2370 2376
14. J. Pinczewski, and A. Slominski The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms Exp Dermatol 19 2010 860 864
15. A. Slominski, D.J. Tobin, S. Shibahara, and J. Wortsman Melanin pigmentation in mammalian skin and its hormonal regulation Physiol Rev 84 2004 1155 1228
16. A.T. Slominski, Z. Janjetovic, and B.E. Fuller Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity PLoS One 5 2010 e9907
17. 2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells Am J Physiol Cell Physiol 300 2011 C526 C541
18. A.A. Brozyna, W. Jozwicki, Z. Janjetovic, and A.T. Slominski Expression of vitamin D receptor decreases during progression of pigmented skin lesions Hum Pathol 42 2011 618 631
19. 3 levels are associated with Breslow thickness at presentation and survival from melanoma J Clin Oncol 27 2009 5439 5444
20. S. Hyter, G. Bajaj, X. Liang, M. Barbacid, G. Ganguli-Indra, and A.K. Indra Loss of nuclear receptor RXRα in epidermal keratinocytes promotes the formation of Cdk4-activated invasive melanomas Pigment Cell Melanoma Res 23 2010 635 648
21. Z. Janjetovic, A.A. Brozyna, and R.C. Tuckey High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives Br J Cancer 105 2011 1874 1884
22. C.M. Balch, J.E. Gershenwald, S.J. Soong, J.F. Thompson, M.B. Atkins, and D.R. Byrd Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
23. A. Slominski, B. Zbytek, and R. Slominski Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells Int J Cancer 124 2009 1470 1477
24. W.H. Clark Jr., D.E. Elder, D.T. Guerry, M.N. Epstein, M.H. Greene, and M. Van Horn A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma Hum Pathol 15 1984 1147 1165
25. W.H. Clark Jr., D.E. Elder, and D.T. Guerry Model predicting survival in stage I melanoma based on tumor progression J Natl Cancer Inst 81 1989 1893 1904
26. 3-1α-hydroxylase expression in normal and malignant human colon J Histochem Cytochem 52 2004 985 989
27. T.C. Chen, and M.F. Holick Vitamin D and prostate cancer prevention and treatment Trends Endocrinol Metab 14 2003 423 430
28. K. Townsend, C.M. Banwell, and M. Guy Autocrine metabolism of vitamin D in normal and malignant breast tissue Clin Cancer Res 11 2005 3579 3586
29. 3-1α-hydroxylase in normal and malignant breast tissue Anticancer Res 26 2006 2615 2620
30. 3-induced growth inhibition Cancer Res 61 2001 2852 2856
31. T.C. Chen, L. Wang, L.W. Whitlatch, J.N. Flanagan, and M.F. Holick Prostatic 25-hydroxyvitamin D-1α-hydroxylase and its implication in prostate cancer J Cell Biochem 88 2003 315 322
32. T.L. Frankel, R.S. Mason, P. Hersey, E. Murray, and S. Posen The synthesis of vitamin D metabolites by human melanoma cells J Clin Endocrinol Metab 57 1983 627 631
33. M. Seifert, W. Tilgen, and J. Reichrath Expression of 25-hydroxyvitamin D-1α-hydroxylase (1α-OHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro Anticancer Res 29 2009 3659 3667
34. 3-responsive and -resistant melanoma cells Cancer Biol Ther 6 2007 48 55
35. J. Reichrath, L. Rafi, M. Rech, V. Meineke, W. Tilgen, and M. Seifert No evidence for amplification of 25-hydroxyvitamin D-1α-OHase (1α-OHase) or 1,25-dihydroxyvitamin D-24-OHase (24-OHase) genes in malignant melanoma (MM) J Steroid Biochem Mol Biol 89-90 2004 163 166
36. J.A. Carlson, A. Slominski, and G.P. Linette Malignant melanoma 2003: predisposition, diagnosis, prognosis, and staging Am J Clin Pathol 120 Suppl. 2003 S101 S127
37. A. Slominski, R. Paus, and M.C. Mihm Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis Anticancer Res 18 1998 3709 3715
38. A.A. Brozyna, L. VanMiddlesworth, and A.T. Slominski Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy Int J Cancer 123 2008 1448 1456